
ASCO 2020: Researchers underscore efficacy of pembrolizumab plus axitinib in treating advanced renal cell carcinoma
Researchers at Fox Chase Cancer Center, USA, along with an international team of investigators, have…
Researchers at Fox Chase Cancer Center, USA, along with an international team of investigators, have…
A study of more than 300,000 individuals in Denmark, presented at this year’s European Congress…
With the swift introduction of approved immunotherapy approaches into the treatment landscape for many cancers,…
A combination of the immune checkpoint blocker, , plus the tyrosine kinase inhibitor (TKI), axitinib,…
A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the…
Two independent studies have begun mapping the connections between and identities of the thousands of…
Mayo Clinic researchers have discovered that surgery could more than double life expectancy for many…
Diets high in meat may lead to an increased risk of developing renal cell carcinoma…